Precision medicine starts here
|18th May 2018
Precision medicine is set to revolutionise the healthcare sector, promising vastly improved outcomes for patients. However, as treatments become more precise, pharma companies will need to create more targeted commercial strategies. Meanwhile, the clinical trial recruitment process will become more challenging and a new series of stakeholders will emerge. These are just some of the barriers.
That’s why have dedicated the latest edition of our ‘Perspective’ magazine to this complex topic. We have combined the views of our in-house precision medicine experts and voices from key industry leaders to give you the latest information on the trend set to redefine healthcare as we know it – precision medicine.
In this edition of ‘Perspective’, we answer the following questions:
- Are we ready for precision medicine?
- How can you master the precision medicine opportunity?
- How can industry drive greater engagement in the clinical trial recruitment process?
- Will precision medicine change the way we interact with patients?
- Who are the new healthcare influencers?
My MS journey: one patient's search for innovation
|18th April 2019
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients.
MIT reveals new pill to deliver insulin
|10th April 2019
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team and reveals the innovative engineering behind the pill.
The problem with the ‘recovery’ conversation in mental health
|4th April 2019
Account Executive Loredana Gogoescu discusses the impact our language can have on people experiencing mental illness, and asks if terms such as 'recovery' are appropriate.